Natco Pharma looks to streamline development to enable faster regulatory approval
Natco Pharma looks to streamline development to enable faster regulatory approval
4 PagesNatco Pharma, an industry leader in generic pharmaceuticals with nine manufacturing facilities and research centers across India, over 4,800 employees, and exports to 50+ countries, transitioned to digital workflows using Revvity Signals Notebook to streamline complex, manual R&D processes. The software digitized report and request generation to save staff time, accelerated data transfer from lab to field, and established robust audit trails for regulatory compliance. This enhanced development control, sped up filings for approval, reduced delays, and strengthened overall efficiency in bringing products to market.
